BOSTON (AP) _ Haemonetics Corp. (HAE) on Tuesday reported fiscal fourth-quarter net income of $9.7 million, after reporting a loss in the same period a year earlier.

The Boston-based company said it had net income of 19 cents per share. Earnings, adjusted for non-recurring costs and restructuring costs, were 65 cents per share.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 60 cents per share.

The provider blood management systems for health care providers and blood collectors posted revenue of $265 million in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $258.4 million.

For the year, the company reported profit of $43.4 million, or 84 cents per share. Revenue was reported as $993.2 million.

Haemonetics expects full-year earnings in the range of $2.50 to $2.90 per share.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HAE at https://www.zacks.com/ap/HAE

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News